Propanc Biopharma Inc (PPCB)

[the gipper]

Upcoming meeting with regulatory authorities in both EU and US regarding Phase I protocol and pathway for Orphan designation reveal mngt's growing confidence based on research of PCP effectiveness in combating cancer is becoming increasingly evident. Having research done in the US which is currently underway was a very smart move in preperation for upcoming meetings. Base of support is obviously growing as daily volume is ramping up with expectations for these upcoming meetins. BP's attention will be seen I believe in the upcoming months...That will change everything! and I think most of you already know it!